Relevance of immunometabolic status for the evaluation of cognitive performance in patients with major depressive disorder

被引：0
|
作者：
Sanchez-Carro, Y. [1 ,2 ,3 ]
De la Torre-Luque, A. [2 ,4 ]
Leal-Leturia, I. [1 ,2 ,3 ]
Pereto-Pamblanco, M. [5 ]
Alvarez, P. [6 ]
Salvat-Pujol, N. [7 ,8 ]
Massaneda, C. [7 ]
Soria, V. [2 ,7 ,9 ]
Lopez-Garcia, P. [1 ,2 ,3 ]
机构：
[1] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain
[2] Carlos III Hlth Inst, Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain
[3] Inst Invest Sanitaria Princesa IIS Princesa, Dept Psychiat, Madrid, Spain
[4] Univ Complutense Madrid, Dept Legal Med Psychiat & Pathol, Madrid, Spain
[5] Neural SL, Inia, Catellon, Spain
[6] Inst Neuropsychiat & Addict, Ctr Forum IMIM Neuropsychiat & Addict, Barcelona, Spain
[7] Bellvitge Biomed Res Inst IDIBELL, Dept Psychiat, Barcelona, Spain
[8] Univ Barcelona, Dept Clin Sci, Barcelona, Spain
[9] Univ Barcelona, Barcelona, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2021年 / 53卷
关键词：
D O I：
10.1016/j.euroneuro.2021.10.344
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.0363
引用
收藏
页码：S264 / S265
页数：2
相关论文
共 50 条
  • [1] Relationship between immunometabolic status and cognitive performance among major depression disorder patients
    Sanchez-Carro, Yolanda
    de la Torre-Luque, Alejandro
    Portella, Maria J.
    Leal-Leturia, Itziar
    Salvat-Pujol, Neus
    Massaneda, Clara
    de Arriba-Arnau, Aida
    Urretavizcaya, Mikel
    Pereto, Mar
    Toll, Alba
    Martinez-Ruiz, Antonio
    Ferreiros-Martinez, Raquel
    Alvarez, Pilar
    Soria, Virginia
    Lopez-Garcia, Pilar
    PSYCHONEUROENDOCRINOLOGY, 2022, 137
  • [2] Evaluation of cognitive impairment in patients with major depressive disorder in remission
    Mustafa Ali
    Magda Fahmy
    Wafaa Haggag
    Ashraf El-Tantawy
    Haydy Hassan
    Middle East Current Psychiatry, 28
  • [3] Evaluation of cognitive impairment in patients with major depressive disorder in remission
    Ali, Mustafa
    Fahmy, Magda
    Haggag, Wafaa
    El-Tantawy, Ashraf
    Hassan, Haydy
    MIDDLE EAST CURRENT PSYCHIATRY-MECPSYCH, 2021, 28 (01):
  • [4] Cognitive Performance in Individuals with Major Depressive Disorder and no Diagnosis
    Molina, Karla
    Abinader, Melodie
    Nunez, Christina
    Golden, Charles
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2023,
  • [5] Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning
    Sanchez-Carro, Yolanda
    de la Torre-Luque, Alejandro
    Leal-Leturia, Itziar
    Salvat-Pujol, Neus
    Massaneda, Clara
    de Arriba-Arnau, Aida
    Urretavizcaya, Mikel
    Perez-Sola, Victor
    Toll, Alba
    Martinez-Ruiz, Antonio
    Ferreiros-Martinez, Raquel
    Perez, Salvador
    Sastre, Juan
    Alvarez, Pilar
    Soria, Virginia
    Lopez-Garcia, Pilar
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2023, 121
  • [6] Cognitive Markers in Suicidal Major Depressive Disorder Patients
    Nemes, B.
    Cozman, D.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [7] Cognitive estimation in aged patients with major depressive disorder
    Barabassy, Agota
    Beinhoff, Ulrike
    Riepe, Matthias W.
    PSYCHIATRY RESEARCH, 2010, 176 (01) : 26 - 29
  • [8] Cognitive impairment in patients with bipolar disorder and major depressive disorder in remission
    Ashenbrenner, Y.
    Chumakov, E.
    Petrova, N.
    EUROPEAN PSYCHIATRY, 2020, 63 : S64 - S64
  • [9] The impact of cognitive reserve on neurocognitive performance in Major Depressive Disorder
    Venezia, Rachel G.
    Gorlyn, Marianne
    Burke, Ainsley K.
    Oquendo, Maria A.
    Mann, J. John
    Keilp, John G.
    PSYCHIATRY RESEARCH, 2018, 270 : 211 - 218
  • [10] Cognitive performance in patients with major depressive disorder treated with vortioxetine compared with escitalopram and venlafaxine
    Fernandez-Miranda, J. J.
    Frias-Ortiz, D. F.
    Diaz-Fernandez, S.
    Rubio-Rodriguez, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S794 - S795
12345